Cel
The aim of TINN is to evaluate ciprofloxacin, fluconazole and micafungin in neonates; two anti-infectious drugs included in the EMEA priority list of the therapeutic areas that need specific drug evaluation in preterm and term neonates. These drugs are prescribed off-label to treat neonatal infections that are life threatening situations and associated with long-term complications. In order to validate the use of these two drugs in these high risk populations, TINN involves European leaders in neonatology, paediatric pharmacology, methodology and SME and has established a close collaboration between academia, ethical bodies, regulatory authorities and pharmaceutical companies. For both drugs, the project will perform in silico experimentations, animal studies and evaluate formulations adapted to neonates. Designs will be optimized using age-appropriate state-of-the-art methods adapted to neonates, include pharmacokinetics and pharmacogenetics in order to validate the components of a Paediatric Investigation Plan. The two trials will be performed with neonatologists trained in paediatric pharmacology and clinical research who respect Good Clinical Practices. All the ethical issues related to the two trials will be considered in particular pain and distress, blood sampling (number and volume) and informed consent. Parent information sheets and consent form submitted to parents’ associations for approval. TINN will include short-term safety (based on vital signs, blood safety data and function of the major
organs) and potential for long-term adverse reactions. Results will be also reported in order to allow a PUMA application and to improve neonatal care, through scientific societies. Therefore, TINN will strengthen the European role in drug evaluation in paediatric patients and will support initiatives of the European pharmaceutical industry. Increasing the appropriate use of medicines in child will be of direct benefit to children, their families and health professionals.
Dziedzina nauki
Słowa kluczowe
Temat(-y)
Zaproszenie do składania wniosków
FP7-HEALTH-2007-B
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research projectKoordynator
75654 Paris
Francja
Zobacz na mapie
Uczestnicy (15)
75015 PARIS
Zobacz na mapie
NG7 2RD Nottingham
Zobacz na mapie
69622 Villeurbanne Cedex
Zobacz na mapie
10126 Torino
Zobacz na mapie
L69 7ZX Liverpool
Zobacz na mapie
3015 GD Rotterdam
Zobacz na mapie
89081 Ulm
Zobacz na mapie
4000 LIEGE
Zobacz na mapie
Zakończenie uczestnictwa
2000 Antwerpen
Zobacz na mapie
37020 Tours
Zobacz na mapie
75012 Paris
Zobacz na mapie
69007 LYON
Zobacz na mapie
1020 Bruxelles
Zobacz na mapie
20156 Milano
Zobacz na mapie
17177 Stockholm
Zobacz na mapie